Missing/wrong data?
Log in to edit
Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial.
scientific article
Author/s
author: Susan Halabi, Darren R Feldman, Michael J. Morris, Toni K Choueiri, Eric J Small
Work details
Publication date
November 14, 2016
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.